Related Experiment Videos

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors

Giovanna D'Andrea1, Rosa D'Ambrosio, Maurizio Margaglione

  • 1Genetica Medica, Dipartimento di Scienze Biomediche, Università di Foggia, Italy.

Blood Reviews
|February 1, 2008
PubMed

Insights

Genetic variations in CYP2C9 and VKORC1 significantly impact oral anticoagulant dosing. Genotype-based models explain much of this variability, improving warfarin therapy management.

Area of Science:

  • Pharmacogenomics
  • Clinical Pharmacology
  • Thrombosis Management

Background:

  • Oral anticoagulants are crucial for thromboembolic disease prevention and treatment.
  • Significant inter-individual variability exists in oral anticoagulant dose requirements.
  • Genetic and environmental factors influence drug response.

Purpose of the Study:

  • To investigate the impact of genetic variations on oral anticoagulant response.
  • To establish genotype-based models for predicting drug dosage.
  • To enhance oral anticoagulant therapy management.

Main Methods:

  • Molecular analysis of CYP2C9 and VKORC1 genes.
  • Genotype-based modeling to assess dose-response relationships.
  • Evaluation of genetic factors influencing oral anticoagulant therapy.

Main Results:

  • Genetic variations in CYP2C9 and VKORC1 strongly affect individual responses to oral anticoagulants.
  • Genotype-based modeling explained a substantial portion of dose variations.
  • Identified key genetic determinants for oral anticoagulant efficacy.

Conclusions:

  • CYP2C9 and VKORC1 genotypes are critical predictors of oral anticoagulant response.
  • Genotype-guided dosing strategies can optimize therapy.
  • Expanding candidate gene analysis will further refine oral anticoagulant management.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...